Anzeige
Mehr »
Donnerstag, 08.01.2026 - Börsentäglich über 12.000 News
Das Wildwest-Silberrevier, das bei 80-Dollar-Silber wichtiger ist denn je!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EYA0 | ISIN: US86272A3059 | Ticker-Symbol: E2O
Lang & Schwarz
07.01.26 | 07:00
2,050 Euro
-100,00 % -2,050
1-Jahres-Chart
STRATA SKIN SCIENCES INC Chart 1 Jahr
5-Tage-Chart
STRATA SKIN SCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,0402,06007.01.

Aktuelle News zur STRATA SKIN SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.12.25STRATA Skin Sciences, Inc. - 8-K, Current Report-
10.12.25STRATA Skin Sciences, Inc. - 8-K, Current Report-
09.12.25STRATA Skin Sciences, Inc.: STRATA Skin Sciences Showcases XTRAC and TheraclearX at TeraCILAD 2025 - Reports Early Adoption Momentum in Mexico1
14.11.25STRATA Skin Sciences, Inc. - 10-Q, Quarterly Report-
14.11.25Strata Skin Sciences outlines threefold market expansion opportunity as CPT code revisions approach 20272
13.11.25STRATA Skin Sciences GAAP EPS of -$0.36 beats by $0.17, revenue of $6.93M misses by $0.79M1
STRATA SKIN SCIENCES Aktie jetzt für 0€ handeln
12.11.25A Peek at Strata Skin Sciences' Future Earnings1
06.11.25STRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion1
05.11.25STRATA Skin Sciences, Inc.: STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update1
29.10.25STRATA Skin Sciences Rises 25% Pre-Market - Here's Why1
16.10.25Strata Skin Sciences reicht Prospektnachtrag für mögliches Aktienangebot über 11 Millionen US-Dollar ein1
14.10.25STRATA Skin Sciences, Inc. - 8-K, Current Report1
14.10.25STRATA Skin Sciences, Inc.: Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides148First English-language case study shows resolution of lesions with 308-nm Excimer laser in rare mycosis fungoides (MF) subtype, poikilodermatous mycosis fungiodes (pMF), underscoring the Company's...
► Artikel lesen
03.10.25Strata Skin Sciences highlights excimer laser efficacy for eczema2
03.10.25Strata Skin Sciences: Klinische Daten stützen Excimer-Laser-Therapie bei Ekzemen1
03.10.25STRATA Skin Sciences, Inc.: Marking Eczema Awareness Month - Clinical Research Validates Strata Skin Sciences' XTRAC Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis1
30.09.25STRATA Skin Sciences, Inc.: STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC Excimer Laser Treatment Combined with a Topical Drug in Psoriasis1
23.09.25Aktie von STRATA Skin Sciences schießt nach vielversprechender Vitiligo-Studie in die Höhe1
23.09.25STRATA Skin Sciences stock soars after promising vitiligo study results1
22.09.25STRATA Skin Sciences, Inc.: New Peer Reviewed Publication of Combination Therapy in Vitiligo with STRATA Skin Sciences' Excimer Laser and JAK Inhibitors Demonstrated Superior Safety and Unprecedented Response Rates, Providing Continued Validation ...9
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1